326 related articles for article (PubMed ID: 9949201)
1. The Friedreich's ataxia mutation confers cellular sensitivity to oxidant stress which is rescued by chelators of iron and calcium and inhibitors of apoptosis.
Wong A; Yang J; Cavadini P; Gellera C; Lonnerdal B; Taroni F; Cortopassi G
Hum Mol Genet; 1999 Mar; 8(3):425-30. PubMed ID: 9949201
[TBL] [Abstract][Full Text] [Related]
2. Frataxin expression rescues mitochondrial dysfunctions in FRDA cells.
Tan G; Chen LS; Lonnerdal B; Gellera C; Taroni FA; Cortopassi GA
Hum Mol Genet; 2001 Sep; 10(19):2099-107. PubMed ID: 11590127
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial damage and senescence phenotype of cells derived from a novel frataxin G127V point mutation mouse model of Friedreich's ataxia.
Fil D; Chacko BK; Conley R; Ouyang X; Zhang J; Darley-Usmar VM; Zuberi AR; Lutz CM; Napierala M; Napierala JS
Dis Model Mech; 2020 Jul; 13(7):. PubMed ID: 32586831
[TBL] [Abstract][Full Text] [Related]
4. Friedreich's ataxia and frataxin: molecular genetics, evolution and pathogenesis (Review).
Palau F
Int J Mol Med; 2001 Jun; 7(6):581-9. PubMed ID: 11351269
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial dysfunction in friedreich's ataxia.
Lodi R; Taylor DJ; Schapira AH
Biol Signals Recept; 2001; 10(3-4):263-70. PubMed ID: 11351132
[TBL] [Abstract][Full Text] [Related]
6. Aconitase and mitochondrial iron-sulphur protein deficiency in Friedreich ataxia.
Rötig A; de Lonlay P; Chretien D; Foury F; Koenig M; Sidi D; Munnich A; Rustin P
Nat Genet; 1997 Oct; 17(2):215-7. PubMed ID: 9326946
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive analysis of gene expression patterns in Friedreich's ataxia fibroblasts by RNA sequencing reveals altered levels of protein synthesis factors and solute carriers.
Napierala JS; Li Y; Lu Y; Lin K; Hauser LA; Lynch DR; Napierala M
Dis Model Mech; 2017 Nov; 10(11):1353-1369. PubMed ID: 29125828
[TBL] [Abstract][Full Text] [Related]
8. Up-regulation of c-Jun N-terminal kinase pathway in Friedreich's ataxia cells.
Pianese L; Busino L; De Biase I; De Cristofaro T; Lo Casale MS; Giuliano P; Monticelli A; Turano M; Criscuolo C; Filla A; Varrone S; Cocozza S
Hum Mol Genet; 2002 Nov; 11(23):2989-96. PubMed ID: 12393810
[TBL] [Abstract][Full Text] [Related]
9. Ferroptosis as a Novel Therapeutic Target for Friedreich's Ataxia.
Cotticelli MG; Xia S; Lin D; Lee T; Terrab L; Wipf P; Huryn DM; Wilson RB
J Pharmacol Exp Ther; 2019 Apr; 369(1):47-54. PubMed ID: 30635474
[TBL] [Abstract][Full Text] [Related]
10. Human mesenchymal stem cells increase anti-oxidant defences in cells derived from patients with Friedreich's ataxia.
Dey R; Kemp K; Gray E; Rice C; Scolding N; Wilkins A
Cerebellum; 2012 Dec; 11(4):861-71. PubMed ID: 22826109
[TBL] [Abstract][Full Text] [Related]
11. Frataxin: its role in iron metabolism and the pathogenesis of Friedreich's ataxia.
Becker E; Richardson DR
Int J Biochem Cell Biol; 2001 Jan; 33(1):1-10. PubMed ID: 11167127
[TBL] [Abstract][Full Text] [Related]
12. Frataxin point mutations in two patients with Friedreich's ataxia and unusual clinical features.
McCormack ML; Guttmann RP; Schumann M; Farmer JM; Stolle CA; Campuzano V; Koenig M; Lynch DR
J Neurol Neurosurg Psychiatry; 2000 May; 68(5):661-4. PubMed ID: 10766903
[TBL] [Abstract][Full Text] [Related]
13. Iron-dependent self-assembly of recombinant yeast frataxin: implications for Friedreich ataxia.
Adamec J; Rusnak F; Owen WG; Naylor S; Benson LM; Gacy AM; Isaya G
Am J Hum Genet; 2000 Sep; 67(3):549-62. PubMed ID: 10930361
[TBL] [Abstract][Full Text] [Related]
14. 'Mitochondrial energy imbalance and lipid peroxidation cause cell death in Friedreich's ataxia'.
Abeti R; Parkinson MH; Hargreaves IP; Angelova PR; Sandi C; Pook MA; Giunti P; Abramov AY
Cell Death Dis; 2016 May; 7(5):e2237. PubMed ID: 27228352
[TBL] [Abstract][Full Text] [Related]
15. Clinical, biochemical and molecular genetic correlations in Friedreich's ataxia.
Bradley JL; Blake JC; Chamberlain S; Thomas PK; Cooper JM; Schapira AH
Hum Mol Genet; 2000 Jan; 9(2):275-82. PubMed ID: 10607838
[TBL] [Abstract][Full Text] [Related]
16. Mesenchymal stem cells restore frataxin expression and increase hydrogen peroxide scavenging enzymes in Friedreich ataxia fibroblasts.
Kemp K; Mallam E; Hares K; Witherick J; Scolding N; Wilkins A
PLoS One; 2011; 6(10):e26098. PubMed ID: 22016819
[TBL] [Abstract][Full Text] [Related]
17. Targeting lipid peroxidation and mitochondrial imbalance in Friedreich's ataxia.
Abeti R; Uzun E; Renganathan I; Honda T; Pook MA; Giunti P
Pharmacol Res; 2015 Sep; 99():344-50. PubMed ID: 26141703
[TBL] [Abstract][Full Text] [Related]
18. The role of mitochondrial labile iron in Friedreich's ataxia skin fibroblasts sensitivity to ultraviolet A.
Reelfs O; Abbate V; Cilibrizzi A; Pook MA; Hider RC; Pourzand C
Metallomics; 2019 Mar; 11(3):656-665. PubMed ID: 30778428
[TBL] [Abstract][Full Text] [Related]
19. Novel aberrant genetic and epigenetic events in Friedreich's ataxia.
Quesada MP; Jones J; Rodríguez-Lozano FJ; Moraleda JM; Martinez S
Exp Cell Res; 2015 Jul; 335(1):51-61. PubMed ID: 25929520
[TBL] [Abstract][Full Text] [Related]
20. Efficient attenuation of Friedreich's ataxia (FRDA) cardiomyopathy by modulation of iron homeostasis-human induced pluripotent stem cell (hiPSC) as a drug screening platform for FRDA.
Lee YK; Lau YM; Ng KM; Lai WH; Ho SL; Tse HF; Siu CW; Ho PW
Int J Cardiol; 2016 Jan; 203():964-71. PubMed ID: 26625322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
